Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers [NA]
Completed clinical trial studying motivational negative symptoms in schizophrenia with biomarkers; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007) [Phase 1]
Phase 1 trial update on MK-8189 assessing safety, tolerability, and pharmacokinetics in participants with schizophrenia and healthy voluntee…
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Lurasidone Effects on Tissue Glutamate in Schizophrenia [Phase 4]
Phase 4 trial updates on lurasidone effects on tissue glutamate in schizophrenia and schizoaffective disorder; results posted after completi…
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study [Phase 1]
Phase 1 first-in-human safety, tolerability, and pharmacokinetics study (TAK-041) in schizophrenia and healthy volunteers completed; results…
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating BI 425809 on cognition and functional capacity in schizophrenia has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study [Phase 3]
A Phase 3 randomized, double-blind trial comparing ziprasidone to olanzapine in recent-onset psychosis (schizophrenia/psychotic disorders) c…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients [Phase 3]
Phase 3 study comparing ziprasidone to risperidone for schizophrenia in Chinese patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia [Phase 3]
Phase 3 trial comparing safety and efficacy of ziprasidone versus risperidone for chronic schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Mozart Relapse Study [Phase 3]
Phase 3 clinical trial update for Mozart Relapse Study in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs [Phase 3]
Phase 3 trial comparing ziprasidone to clozapine for schizophrenia patients who do not respond or tolerate other antipsychotics; study compl…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients [Phase 3]
Phase 3 trial comparing ziprasidone to other atypical antipsychotics in schizophrenia and schizoaffective disorder completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) [Phase 3]
Phase 3 clinical trial update for intramuscular and oral therapy in acute exacerbation of schizophrenia (BIZET Study) conducted by Pfizer/My…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial update on the efficacy and safety of ziprasidone for acute exacerbation of schizophrenia or schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. [Phase 4]
A Phase 4 trial comparing ziprasidone to olanzapine in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 trial of ziprasidone in acute exacerbation of schizophrenia or schizoaffective disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis [Phase 4]
Phase 4 trial updating the efficacy and safety of intramuscular ziprasidone followed by oral ziprasidone for psychosis in schizophrenia/mani…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs [Phase 4]
Phase 4 clinical trial updating on the effects of ziprasidone for schizophrenia or schizoaffective disorder in patients switched from other …
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders [Phase 2]
Phase 2 trial update evaluating the safety and tolerability of oral ziprasidone in children and adolescents with psychotic disorders complet…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients [Phase 4]
Phase 4 trial comparing ziprasidone to aripiprazole in hospitalized schizophrenia or schizoaffective disorder patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients [Phase 4]
Phase 4 open-label, non-comparative switch study of ziprazidone in previously treated schizophrenia patients was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder [Phase 4]
A Phase 4 clinical trial evaluated the effects of cross-titrating antipsychotics with ziprasidone in schizophrenia or schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism [Phase 4]
Phase 4 clinical trial update examining the impact of once-monthly aripiprazole on brain structure and metabolism in patients with schizophr…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment [Phase 1, Phase 2]
A clinical trial update comparing one-month versus three-month paliperidone palmitate treatment in schizophrenia, across Phase 1 and Phase 2…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics [Phase 2]
Phase 2 clinical trial evaluating the effects of basmisanil in cognitive impairment associated with schizophrenia in patients treated with a…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia [Phase 2]
Phase 2 randomized, double-blind, placebo-controlled cross-over study evaluating TAK-041 as add-on to antipsychotics for motivational anhedo…